Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 501

1.

Residual symptoms in depressed patients who respond acutely to fluoxetine.

Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ 3rd, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Apr;60(4):221-5.

PMID:
10221281
2.
3.

The relationship of personality disorders to treatment outcome in depressed outpatients.

Mulder RT, Joyce PR, Luty SE.

J Clin Psychiatry. 2003 Mar;64(3):259-64.

PMID:
12716266
4.

Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.

Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Sep;60(9):580-3.

PMID:
10520975
5.

Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.

Suri RA, Altshuler LL, Rasgon NL, Calcagno JL, Frye MA, Gitlin MJ, Hwang S, Zuckerbrow-Miller J.

J Clin Psychiatry. 2000 Dec;61(12):942-6.

PMID:
11206600
6.

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.

J Clin Psychiatry. 1999 Apr;60(4):226-31.

PMID:
10221282
7.

Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.

Nelson JC, Portera L, Leon AC.

J Clin Psychiatry. 2005 Nov;66(11):1409-14.

PMID:
16420078
8.

Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.

Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RM, Keller MB.

J Clin Psychiatry. 2003 May;64(5):554-61.

PMID:
12755659
9.

Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.

J Clin Psychiatry. 1991 Aug;52(8):329-35.

PMID:
1907963
10.
11.

Personality disorder comorbidity with major depression and response to fluoxetine treatment.

Fava M, Bouffides E, Pava JA, McCarthy MK, Steingard RJ, Rosenbaum JF.

Psychother Psychosom. 1994;62(3-4):160-7.

PMID:
7846259
12.

Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder.

Papakostas GI, Petersen TJ, Iosifescu DV, Summergrad P, Sklarsky KG, Alpert JE, Nierenberg AA, Fava M.

J Clin Psychiatry. 2004 Apr;65(4):543-6.

PMID:
15119918
13.

The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.

Dording CM, Sinicropi-Yao L, Papakostas G, Matthews JD, Nierenberg AA, Fava M, Mischoulon D.

Nord J Psychiatry. 2009;63(5):420-5. doi: 10.1080/08039480903015396.

PMID:
19521922
14.

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.

Thase ME, Blomgren SL, Birkett MA, Apter JT, Tepner RG.

J Clin Psychiatry. 1997 Jan;58(1):16-21.

PMID:
9055832
15.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753
16.

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.

J Clin Psychopharmacol. 2002 Oct;22(5):474-80.

PMID:
12352270
17.
18.
19.
20.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628

Supplemental Content

Support Center